Common Treatment May Be Removed In Alcoholic Hepatitis Trials

Given effect corticosteroids have on patients, US FDA asks whether they can be excluded from use in alcoholic hepatitis clinical trials.

Advancing drug development in alcoholic hepatitis may require removing a key part of the typical treatment from clinical trials.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

Already a subscriber?